Open AccessOnabotulinum Toxin A (Botox) for Spasticity in Patients With Acquired Brain Injury
Author(s) -
Yan Li,
Aleksandra Grobelna
Publication year - 2021
Publication title -
canadian journal of health technologies
Language(s) - English
Resource type - Journals
ISSN - 2563-6596
DOI - 10.51731/cjht.2021.61
Subject(s) - spasticity , traumatic brain injury , medicine , guideline , botulinum toxin , physical medicine and rehabilitation , anesthesia , psychiatry , pathology
No relevant literature was identified regarding the clinical effectiveness or cost-effectiveness of onabotulinum toxin A (Botox) for reducing spasticity in patients with traumatic or non-traumatic–acquired brain injury.
Authors of 1 evidence-based guideline recommend the use of botulinum toxin (subtype and formulation not specified) for the treatment of spasticity associated with traumatic brain injury.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom